Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2022-01-24
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
NCT04101188
The Effects of Sodium and Potassium on Blood Pressure, Vascular Function and Renal Function
NCT01575041
Potassium and Sodium to Control Blood Pressure in Hypertensives
NCT00000509
The Effects of Potassium on Physiological and Cardiovascular Variables in Healthy Persons
NCT00801034
Effects of Potassium Salts on Blood Pressure and Target Organ Damage
NCT00160368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moderate potassium/low sodium
Subjects will consume a diet moderation in potassium and low in sodium.
Placebo
Subjects will receive a placebo capsule on the moderate potassium/low sodium diet and the moderate potassium/high sodium diet
Moderate potassium/high sodium
Subjects will consume a diet moderation in potassium and high in sodium.
Placebo
Subjects will receive a placebo capsule on the moderate potassium/low sodium diet and the moderate potassium/high sodium diet
High potassium/high sodium
Subjects will consume a diet moderation in potassium and high in sodium.
Potassium chloride supplement
Subjects will receive 64 mmol of KCl on the high potassium/high sodium condition.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Potassium chloride supplement
Subjects will receive 64 mmol of KCl on the high potassium/high sodium condition.
Placebo
Subjects will receive a placebo capsule on the moderate potassium/low sodium diet and the moderate potassium/high sodium diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-45 years of age
* all races/ethnicities
* BMI \< 30 kg/m2
* BP \< 130/80 mmHg
Exclusion Criteria
* known heart disease
* diabetes
* kidney disease
* cancer
* inflammatory conditions
* blood clotting disorders
* pregnancy
* adrenal gland disorder
* history of stomach or intestinal bleeding
* history of kidney stones
* serum potassium outside of the normal range
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Delaware
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shannon Lennon
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tower at STAR
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shannon J Lennon
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1465208
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.